Investing
When Low-Priced Stocks Are The Biggest Leaders (CYBI, MNI, BMTI, SPF)
Published:
Is it a worry when the percentage gainers are all low-priced stocks? For some it may be, others will just say it is the normal process.
Cybex International, Inc. (NASDAQ: CYBI) is up 23% at $1.47 and only on 202,000 shares of volume. This is on the heels the company reaching a settlement in the Barnhard product liability suit.
The McClatchy Company (NYSE: MNI) is up 24% at $2.78 and not quite on 2 million shares as of yet. This surge is after the company beat its earnings predictions and after tuting its digital efforts in the world of old media meets new media.
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) is up 17% on 2.8 million shares at $2.40. Biomimetic’s news is that the company announced results of its 30 patient Canadian Augment Rotator Cuff Graft clinical trial and that the results achieved the primary safety endpoint.
Standard Pacific Corp. (NYSE: SPF) is up 18.5% to $4.80 on 6.7 million shares. The single-family homebuilder announced earnings ahead of estimates.
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.